We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6412:TSEHeiwa Corporation Analysis

Data as of 2026-03-17 - not real-time

¥1,931.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Heiwa Corp (6412.T) is trading at ¥1,931, essentially hugging its 20‑day SMA of ¥1,983 and sitting just above a key support level of ¥1,930, while the 50‑day and 200‑day SMAs sit higher at ¥2,017 and ¥2,062, confirming a short‑term bearish bias. Technical signals are mixed: the RSI of 35 suggests the stock is oversold, yet the MACD histogram remains negative and the MACD line sits below its signal, reinforcing bearish momentum. Volatility is modest at 13.5% over the past 30 days and beta is very low at 0.25, indicating limited price swings relative to the market. Fundamentally, the company boasts a staggering 59.8% revenue growth and an operating margin of 26.4%, while its DCF‑derived fair value of ¥7,684 implies roughly 40% upside from current levels. The dividend yield of 4.13% with a 63% payout ratio appears sustainable given strong free cash flow, but the balance sheet is heavily leveraged (debt‑to‑equity ≈ 245) which tempers optimism.
Overall, the stock is deeply undervalued relative to its intrinsic value and growth trajectory, offering a compelling entry point for value‑oriented investors, yet the high leverage and sector‑specific regulatory exposure introduce material risk. The consensus analyst rating of “strong buy” aligns with the upside potential, but investors should monitor debt levels and any regulatory changes affecting the pachinko industry.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • RSI indicating oversold conditions
  • Price near strong support level
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial revenue growth (~60%)
  • Significant valuation gap to DCF fair value
  • Sustainable dividend supported by cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term upside to intrinsic value
  • Low market beta reducing systematic risk
  • Consistent cash generation despite high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth59.80%
P/E Ratio15.3
ROE3.78%
ROA3.38%
Debt/Equity244.94
P/B Ratio0.8
Op. Cash Flow¥37.3B
Free Cash Flow¥34.7B

Technical Analysis

TrendBearish
RSI35.0
Support¥1,930.00
Resistance¥2,020.00
MA 20¥1,983.15
MA 50¥2,017.14
MA 200¥2,062.11
MACDBearish
VolumeIncreasing
Fear & Greed Index79.43

Valuation

Fair Value¥7,684.37
Target Price¥2,740.00
Upside/Downside41.90%
GradeUndervalued
TypeGrowth
Dividend Yield4.13%

Risk Assessment

Beta0.25
Volatility13.46%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.